Altimmune Shareholders Approve All AGM Proposals, Increase Authorized Shares to 400M
Altimmune shareholders approved all proposals at the virtual annual general meeting on April 16, 2026, including the election of nine directors and amendments to increase authorized shares and expand the employee stock purchase plan. The changes aim to support future capital needs and employee incentives.
Tickers: $ALT
Topics: annual general meeting authorized shares capital structure governance shareholder approval